The AP-1/NF-kappaB double inhibitor SP100030 can revert muscle wasting during experimental cancer cachexia (Q60403662)

From Wikidata
Jump to navigation Jump to search
scientific article published on 01 May 2007
edit
Language Label Description Also known as
English
The AP-1/NF-kappaB double inhibitor SP100030 can revert muscle wasting during experimental cancer cachexia
scientific article published on 01 May 2007

    Statements

    The AP-1/NF-kappaB double inhibitor SP100030 can revert muscle wasting during experimental cancer cachexia (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit